NYSE:SOLV Solventum (SOLV) Stock Price, News & Analysis $66.20 +0.60 (+0.91%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$64.52▼$66.5650-Day Range$48.04▼$66.2052-Week Range$47.16▼$96.05Volume1.30 million shsAverage Volume1.07 million shsMarket Capitalization$11.43 billionP/E RatioN/ADividend YieldN/APrice Target$58.25 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Solventum alerts: Email Address Solventum MarketRank™ Stock AnalysisAnalyst RatingReduce1.86 Rating ScoreUpside/Downside12.0% Downside$58.25 Price TargetShort InterestHealthy3.82% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.04Based on 11 Articles This WeekInsider TradingN/AProj. Earnings Growth-11.44%From $6.38 to $5.65 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.24 out of 5 starsMedical Sector704th out of 910 stocksSurgical & Medical Instruments Industry82nd out of 95 stocks 1.9 Analyst's Opinion Consensus RatingSolventum has received a consensus rating of Reduce. The company's average rating score is 1.86, and is based on no buy ratings, 6 hold ratings, and 1 sell rating.Amount of Analyst CoverageSolventum has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Solventum's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted3.82% of the float of Solventum has been sold short.Short Interest Ratio / Days to CoverSolventum has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Solventum has recently decreased by 17.76%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldSolventum does not currently pay a dividend.Dividend GrowthSolventum does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SOLV. Previous Next 3.4 News and Social Media Coverage News SentimentSolventum has a news sentiment score of 1.04. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 11 news articles for Solventum this week, compared to 6 articles on an average week.Search Interest19 people have searched for SOLV on MarketBeat in the last 30 days. This is an increase of 27% compared to the previous 30 days.MarketBeat FollowsOnly 6 people have added Solventum to their MarketBeat watchlist in the last 30 days. This is a decrease of -40% compared to the previous 30 days. Previous Next N/A Company Ownership Insider Buying vs. Insider SellingIn the past three months, Solventum insiders have not sold or bought any company stock.Read more about Solventum's insider trading history. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Solventum are expected to decrease by -11.44% in the coming year, from $6.38 to $5.65 per share.Price to Earnings Growth RatioSolventum has a PEG Ratio of 1.46. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioSolventum has a P/B Ratio of 3.99. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Solventum's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Weiss Ratings“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. About SolventumSolventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.Read More SOLV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SOLV Stock News HeadlinesAugust 12, 2024 | marketbeat.comThis “Lonely, Uncomfortable” Stock Move Delivers Big GainsHere’s one thing most folks get wrong about dividend cuts: They can (and often do) set up terrific buying opportunities! I know, I know. Before our cuSeptember 7 at 11:54 AM | msn.comBTIG Initiates Coverage of Solventum (SOLV) with Neutral RecommendationSeptember 7, 2024 | Crypto 101 Media (Ad)Perfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying with both fists. They know it's only a matter of time before another bull run. Now, Crypto Insiders Are Scooping up Lesser-Known Coins and Making Serious BankSeptember 7 at 4:23 AM | americanbankingnews.comSolventum (NYSE:SOLV) Now Covered by BTIG ResearchSeptember 6 at 4:54 AM | markets.businessinsider.comMaintaining Hold on Solventum Corp: Weighing Transformation Progress Against Near-Term Financial HeadwindsSeptember 3, 2024 | msn.comDon't Miss Out on These Top 3 Stocks for a September to RememberAugust 30, 2024 | 247wallst.com2 Spinoff Stocks Down 16%. Should You Buy Now?August 28, 2024 | prnewswire.comSolventum to Participate in Upcoming Investor ConferencesSeptember 7, 2024 | Crypto 101 Media (Ad)Perfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying with both fists. They know it's only a matter of time before another bull run. Now, Crypto Insiders Are Scooping up Lesser-Known Coins and Making Serious BankAugust 20, 2024 | prnewswire.comSolventum autonomous coding listed in Epic ToolboxAugust 19, 2024 | finance.yahoo.comWith 60% ownership, Solventum Corporation (NYSE:SOLV) boasts of strong institutional backingAugust 18, 2024 | finance.yahoo.comSolventum Corporation (KB7.SG)August 13, 2024 | finance.yahoo.comSeth Klarman's Strategic Moves in Q2 2024: A Closer Look at Humana Inc's Prominent PositionAugust 13, 2024 | msn.comTrian Fund Management Encourages Solventum Corporation (SOLV) to Unlock Shareholder ValueAugust 11, 2024 | seekingalpha.comSolventum Corporation (SOLV) Q2 2024 Earnings Call TranscriptAugust 10, 2024 | seekingalpha.comSolventum Corporation 2024 Q2 - Results - Earnings Call PresentationAugust 9, 2024 | markets.businessinsider.comBank of America Securities Reaffirms Their Hold Rating on Solventum Corporation (SOLV)August 9, 2024 | finance.yahoo.comQ2 2024 Solventum Corp Earnings CallSee More Headlines Receive SOLV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Solventum and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/08/2024Today9/07/2024Next Earnings (Estimated)11/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNYSE:SOLV Previous Symbol: CUSIPN/A CIK1964738 Webwww.solventum.com Phone651-733-1110FaxN/AEmployees22,000Year FoundedN/APrice Target and Rating Average Stock Price Target$58.25 High Stock Price Target$64.00 Low Stock Price Target$54.00 Potential Upside/Downside-12.0%Consensus RatingReduce Rating Score (0-4)1.86 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E Ratio10.38 P/E Growth1.46Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio2.90 Current Ratio1.31 Quick Ratio0.96 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$16.60 per share Price / Book3.99Miscellaneous Outstanding Shares172,710,000Free FloatN/AMarket Cap$11.43 billion OptionableOptionable BetaN/A 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. Bryan C. Hanson (Age 57)CEO & Director Mary T. WilcoxChief Accounting OfficerMs. Amy LanducciChief Information & Digital OfficerMr. Paul S. HarringtonChief Supply Chain OfficerMichael J. OttesenVice PresidentKey CompetitorsZimmer BiometNYSE:ZBHSmith & NephewNYSE:SNNPenumbraNYSE:PENGlaukosNYSE:GKOSStevanato GroupNYSE:STVNView All CompetitorsInstitutional OwnershipSanctuary Advisors LLCBought 9,751 shares on 9/5/2024Ownership: 0.006%NCP Inc.Bought 655 shares on 8/30/2024Ownership: 0.000%Teachers Retirement System of The State of KentuckyBought 11,292 shares on 8/26/2024Ownership: 0.007%Cetera Investment AdvisersBought 700 shares on 8/22/2024Ownership: 0.000%Truist Financial CorpBought 84,837 shares on 8/21/2024Ownership: 0.049%View All Institutional Transactions SOLV Stock Analysis - Frequently Asked Questions How have SOLV shares performed this year? Solventum's stock was trading at $66.90 at the beginning of 2024. Since then, SOLV stock has decreased by 1.0% and is now trading at $66.20. View the best growth stocks for 2024 here. How were Solventum's earnings last quarter? Solventum Co. (NYSE:SOLV) issued its quarterly earnings results on Thursday, August, 8th. The company reported $1.56 EPS for the quarter, topping analysts' consensus estimates of $1.46 by $0.10. The firm's quarterly revenue was up .2% on a year-over-year basis. Who are Solventum's major shareholders? Top institutional shareholders of Solventum include Davis Selected Advisers (2.99%), Nuance Investments LLC (1.27%), Newport Trust Company LLC (1.08%) and Baupost Group LLC MA (1.05%). How do I buy shares of Solventum? Shares of SOLV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:SOLV) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solventum Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Solventum With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
